Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

2024 procedure coding system (NKPK) released in Norway

In October 2023, the Norwegian Directorate of e-Health released the Norwegian Clinical Procedure Codes (NKPK) for 2024. The coding system consists of three parts: NCMP for medical procedures, NCSP for surgical, and NCRP for radiological procedures. A total of 28 new codes will be introduced from January 2024: 10 new surgical procedure codes, 14 new radiology procedure codes, and four new medical procedure codes. Some of the examples are provided below:

  • WDAB81 “Manual closed cardiac (chest) compression”;
  • SPY0CK “Ultrasound of AV fistula”;
  • TSE0LM “PET/MR pelvis”;
  • DQE11 “Injection of therapeutic substance into the larynx”;
  • JFH21 “Laparoscopic proctocolectomy with ileostomy”;
  • NEO10D Thermocoagulation in the pelvis, CT-guided;
  • AAGB20 “Transcranial Direct Current Stimulation (tDCS)”;
  • WEGX90 “Dose planning for proton therapy”;
  • NAO10D “Thermocoagulation in the column, CT-guided”.

See more information in Norwegian here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.